About ArcticZymes
ArcticZymes is a publicly listed company based in Tromsø (Norway) founded in 2009. Recombinant enzymes from arctic species are developed for biotech use. The company has 56 employees. ArcticZymes offers products and services including Salt Active Nucleases, Polymerases, and Ligases. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics. Its legal entity is ArcticZymes Technologies ASA.
Company details
Developer of recombinant enzymes from various arctic species. The product line of the company includes COD Uracil DNA glycosylase, Salt active nuclease, Double-strand specific DNAases, Iso Pol DNA Polymerase, and Shrimp Alkaline Phosphatase (heat-labile enzyme). The following are the examples of some of the research applications of these products Removal of genomic DNA from RNA preparations, Decontamination of PCR master mixes, Dephosphorylation prior to cloning, PCR carry-over prevention, Protein Purification, Complete removal of DNA, PCR product clean-up, and Viscosity reduction.
- Headquarters Tromsø, Norway
- Employees 56
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website arcticzymes.com
- Social LinkedIn X
- Legal Name Arcticzymes Technologies Asa
- Annual Revenue$11.17 M (USD)7.92as on Dec 31, 2025
- Net Profit$966.35 K (USD)14.97as on Dec 31, 2025
- EBITDA$776.85 K (USD)201.7as on Dec 31, 2025
- Latest Funding Round$516.39K (USD), Grant
Apr 2016
- Investors
- Employee Count56
Products & Services of ArcticZymes
ArcticZymes offers a comprehensive portfolio of products and services, including Salt Active Nucleases, Polymerases, and Ligases.
Enzymes for degrading DNA in high-salt environments for viral vectors
For DNA amplification in research and diagnostics applications
Enzymes for joining DNA in molecular research and therapeutics
Funding Insights of ArcticZymes
- Total Rounds 1
- Last Round Grant — $516,389
- First Round $516,389
(Apr 2016)
- Investors Count 1
All 1 funding rounds of ArcticZymes with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2016 | $516,389 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in ArcticZymes
ArcticZymes has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ArcticZymes
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ArcticZymes
13 people are tracked at ArcticZymes (4 in leadership, 3 in board & advisors, 6 in team); the tracked headcount is 56.
| Name | Role | Group |
|---|---|---|
Jethro Holter | CEO | Leadership |
Jeremy Gillespie | VP, Corporate Development | Leadership |
Dirk Hahneiser | VP, Business Development & Marketing | Leadership |
Børge Sørvoll | CFO | Leadership |
Jane Theaker | Director | Board & advisors |
Edgar Koster | Director | Board & advisors |
Marit Sjo Lorentzen | Director | Board & advisors |
Vera Taveira | Gerente De Relacionamento | Team |
Khan Rizwan | Technician | Team |
Dag Grønvoll | Corporate Marketing Coordinator | Team |
Christina Vanice Tito Ferreira Alves | Gerente De Pesquisa E Desenvolvimento | Team |
Vimal kumar Sharma | Sales officer , agronomist | Team |
Amina Mokhtar | Leader Of Scentific Researches | Team |
Complete people profiles for ArcticZymes
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ArcticZymes
ArcticZymes is a publicly listed company on the OSL with ticker symbol AZT in Norway, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Nov 2007
- Listed onFRA: B4V
- Listed entityArcticZymes Technologies ASA
- Exchange sectorHealth technology
- ISINNO0010014632
- Share price19.00 NOK (-1.04% on the day) · 2026-10-14
- Market capitalisation980,570,767.00 NOK
- Price to earnings60.6
- EPS (diluted, trailing year)0.31 NOK
- Volume (last session)22,532
Financials of ArcticZymes
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 112.6M NOK | 9.7M NOK | 7.8M NOK |
| 2024 | 104.3M NOK | 8.5M NOK | 2.6M NOK |
| 2023 | 118.9M NOK | 19.4M NOK | 22.2M NOK |
| 2022 | 137.0M NOK | 32.9M NOK | 40.9M NOK |
| 2021 | 128.0M NOK | 46.4M NOK | 59.1M NOK |
Detailed financial statements for ArcticZymes
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of ArcticZymes
3 dated milestones of ArcticZymes across 9 years, from founding to its latest funding, stage changes and deals.
- IPO Lists on the stock exchange (IPO).
- Founded ArcticZymes is founded.
- Funding First funding round of $516K.
Web traffic of ArcticZymes
The website of ArcticZymes (arcticzymes.com) receives about 4.8K visits a month.
- Monthly visits4.8K
▼ 15% vs previous month
Websites whose visitors overlap most with ArcticZymes. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
labgene.ch | labgene.ch | 100% | #10,852,321 | – | |
filgen.jp | filgen.jp | 98% | #1,331,143 | – | |
| tataa.com | 84% | View details | |||
genecraft.de | genecraft.de | 82% | – | ||
| taq-dna.com | 81% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for ArcticZymes
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Arcticzymes
Complete news archive for ArcticZymes
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ArcticZymes
ArcticZymes was founded in 2009 and raised its 1st funding round 7 years after it was founded.
ArcticZymes is headquartered in Tromsø, Norway. It is registered at Tromsø, Troms Og Finnmark, Norway.
ArcticZymes has 56 employees.
Annual revenue of ArcticZymes is $11.17M as on Dec 31, 2025.
Developer of recombinant enzymes from various arctic species. The product line of the company includes COD Uracil DNA glycosylase, Salt active nuclease, Double-strand specific DNAases, Iso Pol DNA Polymerase, and Shrimp Alkaline Phosphatase (heat-labile enzyme). The following are the examples of some of the research applications of these products Removal of genomic DNA from RNA preparations, Decontamination of PCR master mixes, Dephosphorylation prior to cloning, PCR carry-over prevention, Protein Purification, Complete removal of DNA, PCR product clean-up, and Viscosity reduction.
ArcticZymes offers Salt Active Nucleases, Polymerases, and Ligases.
Yes, ArcticZymes is publicly traded on OSL under the ticker symbol AZT.
ArcticZymes has 1 investor. Key investors include European Union.
ArcticZymes operates through Arcticzymes Technologies Asa.